Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Strong Sell

Exponential Moving Average

Sell

Relative Strength Index

Strong Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Pasithea Therapeutics Corp. Common Stock (KTTA)

Pharmaceutical Preparations

https://www.pasithea.com

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.

2110 NARCISSUS CT
VENICE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/15/2021

Market Cap

4,854,037

Shares Outstanding

1,040,000

Weighted SO

1,041,831

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

NTRBW --.--%

ZIVO --.--%

MNOV --.--%

ELYM --.--%

VRAX --.--%

BWV --.--%

REVB --.--%

HILS --.--%

KPRX --.--%

Beta

0.7570

Last Div

0.0000

Range

4.4-17.4

Chg

0.0991

Avg Vol

10740

Mkt Cap

4854037

Exch

NASDAQ

Country

US

Phone

702 514 4174

DCF Diff

-8.5875

DCF

13.2475

Div Yield

0.0000

P/S

4.9718

EV Multiple

2.0120

P/FV

0.0003

Div Yield %

0.0000

P/E

-0.0013

PEG

0.0000

Payout

0.0000

Current Ratio

6.1960

Quick Ratio

6.1960

Cash Ratio

5.7121

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.5015

Op Margin

-4054.0700

Pretax Margin

-3972.8873

Net Margin

-3972.9046

Eff Tax Rate

0.0000

ROA

-0.2196

ROE

-0.9550

ROCE

-0.2433

NI/EBT

1.0000

EBT/EBIT

0.9800

EBIT/Rev

-4054.0700

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

619601.2642

CF/Debt

0.0000

Equity Multi

1.0920

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0074

Asset Turnover

0.0001

OCF/Share

-9.8600

FCF/Share

-9.8382

Cash/Share

7636.8038

OCF/Sales

-10.5367

FCF/OCF

0.9978

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

-453.2732

Div&CapEx Cov

-453.2732

P/BV

0.0003

P/B

0.0003

P/S

4.9718

P/E

-0.0013

P/FCF

-0.4729

P/OCF

-0.4715

P/CF

-0.4715

PEG

0.0000

P/S

4.9718

EV Multiple

2.0120

P/FV

0.0003

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 02, 08:35 Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients GlobeNewswire Inc. Dec 28, 17:00 Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023 GlobeNewswire Inc. Dec 19, 17:19 Pasithea Therapeutics Announces Results from 2023 Annual Meeting GlobeNewswire Inc. Nov 29, 16:27 Pasithea Therapeutics Announces Adjournment of 2023 Annual Meeting of Stockholders GlobeNewswire Inc. Nov 29, 16:27 Pasithea Therapeutics Announces Adjournment of 2023 Annual Meeting of Stockholders

Revenue Product Segmentation